Finally, it was the workers’ turn.
Last Wednesday, Bayer chief executive Werner Baumann and board member Liam Condon had dozens of interviews about the purchase of American seeds and pesticides maker Monsanto. The executives from German drugs and pesticides maker Bayer spoke via webcast from a conference room in New York to their workers in Leverkusen, its headquarters, and Monheim, the main seat of its agrochemicals business.
The Bayer workers asked a lot of questions and touched on some tricky points. What does this mean for their jobs? How will management deal with criticism by environmental associations? And how does management see the monopoly problem?